NRC FORM 374

~

4. Expiration date December 31, 201 1 5. Docket No. 030-35898

U.S. NUCLEAR REGULATORY COMMISSION

Licensee

PAGE 1 OF 2 PAGE5 Amendment No. 10

In accordance with the letter dasd August 11,2010, 3. License number 21-32342-01 is amended in its entirety to read as follows:

/

I. Grand View Health System

2. N10561 Grand View Lane Ironwood, MI 49938-9359

Reference No.

6. Byproduct, source, andlor special nuclear 7. Chemical andlor physical form 8. Maximum amount that licensee may materia I possess at any one time under this

license

A. Any byproduct material permitted by 10 CFR 35.100

B. Any byproduct material permitted by 10 CFR 35.200

C. Iodine-131 permitted by 10 CFR 35.300

A. Any

B. Any

C. Any

A. Asneeded

€3. Asneeded

C. 100 Millicuries

9. Authorized use:

A. Any uptake, dilution and excretion study permitted by 10 CFR 35.100.

€3. Any imaging and localization study permitted by 10 CFR 35.200.

C. Any iodine-I31 diagnostic procedure permitted by 10 CFR 35.300.

CONDITIONS

Licensed material shall be used only at the licensee's facilities located at N10561 Grand View Lane, Ironwood, Michigan.

I O .

11. The Radiation Safety Officer for this license is Donna M. Cataldo, M.D.

12. Licensed material is only authorized for use by, or under the supervision of:

A. Individuals permitted to work as an authorized user in accordance with 10 CFR 35.13 and 35.14.

8. The following individuals are authorized users for medical use as indicated:

MATERIALS LICENSE SUPPLEMENTARY SHEET

NRC FORM 374A US. NUCLEAR REGULATORY COMMISSION PAGE 2 of 2 PAGE: License Number 21 -32342-0 1 Docket or Reference Number 030-35898

Amendment No. 10

13.

14.

Authorized Users

Christopher Mehall, M.D.

John Michael Pap, M.D.

Paresh D. Dixit, M.D.

Frank Matheu, D.O.

Donna M. Cataldo, M.D.

Harry W. Skye, M.D.

Material and Use

10 CFR 35.100, 35.200 and iodine-131, limited to diagnostic studies

10 CFR 35.200

10 CFR 35.100, 35.200 and iodine-131, limited to diagnostic studies

10 CFR 35.100, 35.200 and iodine-131, limited to diagnostic studies

10 CFR 35.100 and 35.200.

10 CFR 35.100, 35.200 and iodine-131, limited to diagnostic studies

The licensee is authorized to transport licensed material in accordance with the provisions of 10 CFR Part 71, "Packaging and Transportation of Radioactive Material."

Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.

A. Application dated August 15, 2001 (excluding references to QMP);

6. Letters dated August 15, 2001, December 7, 2001 (excluding negative declaration for QMP), July 12, 2002 (with enclosures), March 3, 2005, and September 6, 2005;

C. Facsimile dated December 18, 2001;

D. Letter received July 5, 2005; and

E. Memorandum dated June 28, 2005.

FOR THE U.S. NUCLEAR REGULATORY COMMISSION 2-- --.

3ate SEP 2 3 2010 BY

William P. Reichhold Materials Licensing Branch Region I l l